Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.